UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

The New England journal of medicine, 2010-07, Vol.363 (3), p.245-256

2010

Volltextzugriff (PDF)

Challenges in IBD Research: Environmental Triggers

Inflammatory bowel diseases, 2019-05, Vol.25 (Suppl 2), p.S13-S23

2019

Volltextzugriff (PDF)

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1139-1148

2013

Volltextzugriff (PDF)

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B

Circulation (New York, N.Y.), 2006-10, Vol.114 (16), p.1729-1735

2006

Volltextzugriff (PDF)

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Journal of pharmaceutical and biomedical analysis, 2013-05, Vol.78-79, p.39-44

2013

Volltextzugriff (PDF)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases

Proteomes, 2018-03, Vol.6 (2), p.17

2018

Volltextzugriff (PDF)

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756284818771674-1756284818771674

2018

Volltextzugriff (PDF)

Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.281

2010

Volltextzugriff (PDF)

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Sleep (New York, N.Y.), 2008-12, Vol.31 (12), p.1663-1671

2008

Volltextzugriff (PDF)

Fr488 TARGETED DELIVERY OF SOLUBLE TOFACITINIB CITRATE TO THE SITE OF INFLAMMATION TO IMPROVE EFFICACY AND SAFETY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-328-S-328

2021

Volltextzugriff (PDF)

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D2/D3 receptor antagonist, in patients with gastroparesis

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (3), p.267-280

2021

Volltextzugriff (PDF)

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D 2 /D 3 receptor antagonist, in patients with gastroparesis

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (3), p.267-280

2021

Volltextzugriff (PDF)

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

The New England journal of medicine, 2010-07, Vol.363 (3), p.245-256

2010

Volltextzugriff (PDF)

Su599 DEVELOPMENT OF A NOVEL DRUG DELIVERY SYSTEM 2 (DDS2) FOR COLON TARGETED DELIVERY TREATMENT OF ULCERATIVE COLITIS (UC)

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-751-S-751

2021

Volltextzugriff (PDF)

S1282 Evaluation of Smart Capsule Bacterial Detection System (SCBDS) Assay and Duodenal Culture in Subjects Suspected of SIBO and Undergoing Upper Endoscopy: Interim Analysis

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S644-S644

2020

Volltextzugriff (PDF)

S0507 SIBO Diagnosis: Clinical Survey of Practice Patterns, Unmet Needs, and Perception of a Novel Ingestible Diagnostic Capsule

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S236-S237

2020

Volltextzugriff (PDF)

Primary sclerosing cholangitis in children: a histologic follow-up study

Pediatric and developmental pathology, 2005-09, Vol.8 (5), p.568-576

2005

Volltextzugriff (PDF)

S804 Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC)

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e574-e574

2022

Volltextzugriff (PDF)

1178 Accuracy of Glucose Breath Testing for Small Intestine Bacterial Overgrowth (SIBO) Using Endoscopy Aspirate Cultures as a Reference Standard: A Meta-Analysis

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S660-S660

2019

Volltextzugriff (PDF)

Su1809 – A Comparision Study of Systemic Versus Targeted Intracecal Anti-TNFα Monoclonal Antibody in an Adoptive T-Cell Transfer Muine Model of Colitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-620-S-621

2019

Volltextzugriff (PDF)

Sa1717 – Development of a Swallowable Diganostic Capsule to Monitor Gastrointestinal Health

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-376-S-376

2019

Volltextzugriff (PDF)

851 Targeted Intracecal anti-α4β7 Integrin Antibody Results in Reduce Accumulation of α4β7 Memory T-cells in Gut Tissue in DSS-induced Colitis Mice

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S491-S491

2019

Volltextzugriff (PDF)

1179 Characterization of the Bacterial Makeup and Quantitative Distribution in Patients With Suspected Small Intestine Bacterial Overgrowth (SIBO): A Meta-Analysis

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S660-S660

2019

Volltextzugriff (PDF)

Su1875 – Development of Targeted Therapeutic Antibodies for the Treatment of Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-645-S-646

2019

Volltextzugriff (PDF)

Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome

Current medical research and opinion, 2019-03, Vol.35 (3), p.461-472

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(93)

Sprache

Englisch
(93)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Humans
(33)
Female
(17)
Gastroenterology & Hepatology
(16)
Male
(16)
Biological And Medical Sciences
(15)
Adult
(12)
Medical Sciences
(12)
Middle Aged
(11)
Gastroenterology And Hepatology
(10)
Adolescent
(9)
Child
(9)
Aged
(7)
Child, Preschool
(7)
Young Adult
(7)
Animals
(5)
Chemistry
(5)
Follow-Up Studies
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

Challenges in IBD Research: Environmental Triggers

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Fr488 TARGETED DELIVERY OF SOLUBLE TOFACITINIB CITRATE TO THE SITE OF INFLAMMATION TO IMPROVE EFFICACY AND SAFETY

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D2/D3 receptor antagonist, in patients with gastroparesis

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D 2 /D 3 receptor antagonist, in patients with gastroparesis

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

Su599 DEVELOPMENT OF A NOVEL DRUG DELIVERY SYSTEM 2 (DDS2) FOR COLON TARGETED DELIVERY TREATMENT OF ULCERATIVE COLITIS (UC)

S1282 Evaluation of Smart Capsule Bacterial Detection System (SCBDS) Assay and Duodenal Culture in Subjects Suspected of SIBO and Undergoing Upper Endoscopy: Interim Analysis

S0507 SIBO Diagnosis: Clinical Survey of Practice Patterns, Unmet Needs, and Perception of a Novel Ingestible Diagnostic Capsule

Primary sclerosing cholangitis in children: a histologic follow-up study

S804 Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC)

1178 Accuracy of Glucose Breath Testing for Small Intestine Bacterial Overgrowth (SIBO) Using Endoscopy Aspirate Cultures as a Reference Standard: A Meta-Analysis

Su1809 – A Comparision Study of Systemic Versus Targeted Intracecal Anti-TNFα Monoclonal Antibody in an Adoptive T-Cell Transfer Muine Model of Colitis

Sa1717 – Development of a Swallowable Diganostic Capsule to Monitor Gastrointestinal Health

851 Targeted Intracecal anti-α4β7 Integrin Antibody Results in Reduce Accumulation of α4β7 Memory T-cells in Gut Tissue in DSS-induced Colitis Mice

1179 Characterization of the Bacterial Makeup and Quantitative Distribution in Patients With Suspected Small Intestine Bacterial Overgrowth (SIBO): A Meta-Analysis

Su1875 – Development of Targeted Therapeutic Antibodies for the Treatment of Inflammatory Bowel Disease

Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome

Suchergebnisse filtern